Magritek

Magritek, founded by Sir Paul Callaghan, makes benchtop Nuclear Magnetic Resonance (NMR) solutions, which measure the chemical properties of substances for research and industry

Rangatira is invested alongside management, employees and other shareholders.  In 2021, US healthcare technology investor Ampersand Capital took a 5% share, and now holds a 20% stake. 

Website

Investment Date  2013

Ownership Interest  24%

Primary Contact   Mark Dossor